文档介绍：ⅢA期非小细胞肺癌手术前后化疗比较
【关键词】非小细胞肺癌
【Abstract】 AIM: To study the effects of neoadjuvant therapy before operation and adjuvant chemotherapy after operation in cases of nonsmall cell lung cancer in ⅢA stage. METHODS: 62 cases of nonsmall cell lung cancer in ⅢA stage were divided into two groups at random: group A (32 cases) and group B (30 cases). Group A was given neoadjuvant therapy before operation and group B was given adjuvant chemotherapy after operation. RESULTS: The mean living time of group A was 29 months and that of group B was 27 months. The oneyear survival rate, twoyear survival rate and threeyear survival rate of group A were %(26/32),%(15/32) and %(12/32)respectively. The oneyear survival rate, twoyear survival rate and threeyear survival rate of group B were %(25/30),%(14/30) and %(10/30)respectively. The parameters between group A and group B had no significant difference (P>). CONCLUSION: Neoadjuvant therapy is not significantly related to the oneyear, twoyear or threeyear survival rate after operation.
【Keywords】 nonsmall cell lung cancer; chemotherapy; sugery; survival rate
【摘要】目的: 通过病例对比,研究手术前新辅助化疗及手术后化疗对改善ⅢA期非小细胞肺癌患者生存率的影响. 方法: ⅢA期非小细胞细胞肺癌患者62例A组(32例)术前给予新辅助化疗,B组(30例)术后行辅助化疗. 结果: 中位生存时间A组29 mo,B组27 mo. A组1 %(26/32),2 %(15/32),3 %(12/32); %(25/30),%(14/30)%(10/30). A、B组相应指标比较, 均无显著性